Co-Chairs: A. Eniu, CH - E. Senkus, PL
Host Chairs: M. Krzakowski, PL - I. Skoneczna, PL
Honorary Advisor: N. Pavlidis, GR
Advisor: A. Elme, EE
The 8th Eastern European Masterclass in Medical Oncology is a closed event for selected participants only.
The Masterclass will be entirely in English and fluency in English is necessary for admission.
Aims, objectives and teaching format
The Masterclass is a full immersion, clinical oriented event designed for medical and clinical oncologists focusing on multidisciplinarity. The programme will expose participants to a full spectrum of issues in clinical and medical oncology from basic science to advanced knowledge of systemic therapy as well as the multidisciplinary treatment approach. It offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines. Participants will deliver case presentations within tumour boards and discuss them with an international faculty of top experts of each tumour type.
IDEAL PROFILE OF THE MASTERCLASS CANDIDATE
• Age between 30 and 40 years
• At least 2-3 years’ experience in medical oncology or clinical oncology
• Involvement in scientific activities
• Fluency in English
The Online Masterclass will be carried out in two different parts:
Pre-recorded sessions will be made available via this website. You will be able to see all the sessions in your own time.
The pre-recorded sessions must be viewed before block 2 (Live event).
When you finish watching a set of sessions on a specific tumour, please send us up to 3 questions related to the sessions. Some of your questions will be selected and answered during part 2 in the Q&A sessions.
The in person event will be held from 21-25 May 2022.
During the live event, a lecture will be delivered for each main tumour group and will cover topics of interest for oncologists working in the Eastern European area. Each lecture will be followed by a Q&A session using some of the questions that were sent for block 1.
All participants will present a clinical case and discuss it with the experts.
It is possible we may need to change the participants' case topic in order to keep a balance between all tumour types.
Check e-ESO to broaden your knowledge!
Anne Arber, University of Surrey, Faculty of Health and Medical Sciences, Guildford, UK
Joerg Beyer, University Hospital of Bern, Oncology and Medicine Dept., Bern, CH
Giovanni Boniolo, University of Ferrara, Dept. of Biomedical and Surgical Specialist Sciences, Ferrara, IT
Tomasz Borkowski, St. Elizabeth Hospital, Urology Department, Warsaw, PL
Snezana Bosnjak, Institute of Oncology and Radiology of Serbia: ESMO Designated Centre of Integrated Oncology and Palliative Care, Supportive Oncology & Palliative Care Dpt., Belgrade, RS
Felipe A. Calvo Manuel, Clinica Universidad de Navarra, Dept. of Radiation Oncology, Madrid, ES
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, PT
Maria-João Cardoso, Champalimaud Foundation, Breast Unit, Lisbon, PT
Alberto Costa, European School of Oncology, Director's Office, Milano, IT
Agnes Csikos, Palliative Hospice Tanszék, Palliative Care, Pecs, HU
Tanja Cufer, University of Ljubljana, Medical Faculty, Ljubljana, SI
Giuseppe Curigliano, European Institute of Oncology / University of Milan, New Drugs for Innovative Therapies Division, Milano, IT
Sara De Dosso, Oncology Institute of Southern Switzerland (IOSI), Medical Oncology Dpt., Bellinzona, CH
Rodrigo Dienstmann, Vall d’Hebron Institute of Oncology, Molecular Therapeutic Research Unit, Barcelona, ES
Andreas Dietz, University Hospital Leipzig, ENT Dpt., Leipzig, DE
Monika Durzynska, Marie Sklodowska-Curie Memorial Oncology Centre, Pathology Department, Warsaw, PL
Rafal Dziadziuszko, Medical University of Gdansk, Oncology and Radiotherapy Dpt., Gdansk, PL
Anneli Elme, North Estonian Regional Hospital Cancer Centre, Dept. of Chemotherapy, Tallinn, EE
Alexandru Eniu, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Enriqueta Felip, Vall d'Hebron University Hospital, Dept. of Oncology, Barcelona, ES
Karim Fizazi, Gustave Roussy Institute, Cancer Medicine Dept., Villejuif, FR
Martin Früh, St. Gallen Cantonal Hospital, Dept. of Internal Medicine, St. Gallen, CH
Katarzyna Furrer, University Hospital Zurich, Dept. of Thoracic Surgery, Zurich, CH
Marina Garassino, National Cancer Institute - IRCCS Foundation, Medical Oncology Dept., Milano, IT
Fady B. Geara, Cleveland Clinic Abu Dhabi, Dept. of Radiation Oncology, Abu Dhabi, AE
Robert Glynne-Jones, Mount Vernon Centre for Cancer Treatment, Radiotherapy Department, London, UK
Antonio González Martín, Clínica Universidad de Navarra, Oncology Dept., Madrid, ES
Federica Grosso, Azienda Ospedaliera Nazionale SS. Antonio e Biagio e C. Arrigo, ., Alessandria, IT
Andrew Hoy, Epsom, UK
Samia Hurst Majno, Université de Genève, Ethics Dpt., Geneve, CH
Izidor Kern, University Clinic Golnik, Dept. of Pathology, Golnik, SI
Dorota Kiprian, Centre of Oncology, Dept. of Head and Neck Tumours, Warsaw, PL
Jaroslaw Kobiela, Medical University of Gdansk, Poland, Dept. of General, Endocrine and Transplant Surgery, Gdansk, PL
Romuald Krajewski, Marie Sklodowska-Curie Memorial Oncology Centre, Department of Head and Neck Tumours, Warsaw, PL
Stephanie Kroeze, University Hospital Zurich, Radio-Oncology Dept., Zurich, CH
Maciej Krzakowski, The Maris Sklodowska-Curie Memorial Oncology Centre, Dept. of Lung and Thoracic Tumors, Warsaw, PL
Pawel Kurzawa, Which is the standard treatment for stage IB2-IIA cervical cancer?
Aleksandra Lacko, Clinical Hospital, Dept of Oncology, Wroclaw, PL
Angela Lamarca, The Christie NHS Foundation Trust, Medical Oncology Dept, Manchester, UK
Marcin Ligaj, Marie Sklodowska-Curie Memorial Oncology Centre, Pathology Department, Warsaw, PL
Domenica Lorusso, Gemelli University Hospital, Gynecological Oncology Unit, Roma, IT
Radoslaw Madry, Poznan University, Faculty of Medicine, Poznan, PT
Daniela Mosoiu, Hospice Casa Sperantei, Palliative Care Dpt., Brasov, RO
Nicolas Mottet, University Jean Monnet, Dept. of Urology, Saint Etienne Cedex 2, FR
Andrzej Mroz, Marie Sklodowska-Curie Memorial Oncology Centre, Department of Gastroenterology and Hepatology, Warsaw, PL
Wojciech Olszewski, Oncology Center, Breast Cancer Dept., Warsaw, PL.
Olivia Pagani, Riviera-Chablais Hospital, Interdisciplinary Oncology Service, Rennaz, CH
Anes Pasic, Clinical Center University of Sarajevo, Oncology Dept., Sarajevo, BA
Fedro Alessandro Peccatori, European Institute of Oncology, Dept. of Fertility and Procreation in Oncology, Milano, IT
Graeme John Poston, Aintree University Hospital, Dept. of Surgery, Liverpool, UK
Piotr Potemski, Institute of Oncology, Dept.Chemotherapy, Lodz, PL
Giancarlo Pruneri, National Cancer Institute, IRCCS Foundation, Pathology Dpt., Milano, IT
Amanda Psyrri, Attikon University Hospital, Medical Oncology Dept., Chaidari, GR
Isabelle Ray-Coquard, Léon Bérard Center, Dept. of Medical Oncology, Lyon, FR
Christian Rolfo, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Center for Thoracic Oncology, New York, US
Laura Rubbia-Brandt, Hôpitaux Universitaires Genève, Pathology Dept., Geneve, CH
Ales Ryska, Charles University, The Fingerland Department of Pathology, Prague, CZ
Elzbieta Senkus, Medical University of Gdansk, Dept. of Oncology and Radiotherapy, Gdansk, PL
Cristiana Sessa, Istituto Oncologico della Svizzera Italiana, Gynaecology Dpt., Bellinzona, CH
Thomas Seufferlein, Ulm University Hospital, Dept. of Internal Medicine I, Ulm, DE
Iwona Skoneczna, M. Sklodowska-Curie Memorial, ., Warsaw, PL
Bartosz Splawski, Marie Sklodowska-Curie Memorial Oncology Centre, Head and Neck Clinic, Warsaw, PL
Arndt Vogel, Medizine Hochschule Hannover, Gastrointestinal Oncology Dpt., Hannover, DE
Ursula Vogl, Cantonal Hospital of Southern Switzerland (EOC), IOSI - Oncology Institute of Southern Switzerland, Bellinzona, CH
Wojciech Wysocki, Maria Sklodowska-Curie Memorial Institute Of Oncology, Scientific Editorial Office, Warsaw, PL
Ignacio Zapardiel, La Paz University Hospital, Gynecologic Oncology Unit, Madrid, ES
Marcin Zielinski, Pulmonary Hospital, Department of Thoracic Surgery, Zakopane, PL
Jakub Zolnierek, Marie Sklodowska-Curie Memorial Oncology Centre, Urology Department, Warsaw, PL
The Masterclass will be held in English and translation will not be provided.
Participants will be issued a certificate of attendance (minimum attendance: 75% of the online part + 100% of the in person event). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be issued by email.
Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE). The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.
ESCO - The ESO College
Being selected to take part in an ESO Masterclass is one of the ESO activities that gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.
A Masterclass also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits.
Full and active participation in the Masterclass earns participants 30 ESCO credits.
Visit www.ESCO.org for more information on how to join ESCO.
Use the hashtag #ESOexperience and follow us on Facebook, Twitter and Instagram: @esoncology
Should you have any queries, please do not hesitate to contact the event organisers:
Mariachiara Deleo - firstname.lastname@example.org
Dolores Knupfer - email@example.com
ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY
PARTICIPANT’S PROFILE OF THE MASTERCLASS CANDIDATE
- Age between 30 and 40 years
- 2-3 years’ experience in medical oncology
- Involvement in scientific activities and clinical trials
- Fluency in English
Successful applicants are granted free registration.
Accommodation at the masterclass venue for arrival on the 21 May and departure on the 25 May will be provided to participants not residing in the Warsaw area.
HOW TO APPLY
Interested oncologists should apply online (at the top of this page) providing:
- Letter describing motivation for attending;
- Supporting letter from head of department or mentor;
- CV with list publications (if the list of publications is not provided, it will be assumed that no articles have been published)
- Clinical case (see below)
- Professional experience form (see below)
- Ethical case (see below)
Priority will be given to candidates practicing in the Eastern European countries.
CLINICAL CASE PRESENTATION
You will have to present a clinical case at the Masterclass as a clinical grand round discussion. Please provide a straightforward case of your daily clinical practice - no uncommon or extremely rare cases. A maximum of 10 slides will be permitted containing:
- Diagnostic considerations
- Results, follow-up
- At least three questions proposed for discussion with the faculty
Before you start completing the online application form, please be sure you have all the requested files (CV, Motivation letter, Supporting letter, Professional experience template and Clinical Case template) ready to be uploaded to the system. Online applications will not be complete unless all the files are uploaded.